title: Within-class differences of the sulfonylureas should be accounted for.
authors: Diabetes Centre, Isala Clinics, Dokter Spanjaardweg 11, 8025 BT, Zwolle, the Netherlands, d.schrijnders@isala.nl.
authors: Dennis
authors: D
authors: Schrijnders
authors: Nanne
authors: N
authors: Kleefstra
authors: Gijs W D
authors: GW
authors: Landman
mesh_terms: D001786:Blood Glucose / Q000378:metabolism*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D005905:Glyburide / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D008297:Male
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D005905:Glyburide